You will find the exact titration timeline used in clinical trials, the reasoning behind each escalation step, what to do when side effects force you to slow down, and how to calculate your injection volumes based on common vial sizes
ARG was performed to validate PET results
Seriously, I can't stress this enough
The REWIND trial with dulaglutide included many patients without established ASCVD and demonstrated a consistent reduction in MACE, supporting a role in primary prevention, although the effect size was modest
Two copper peptides with different tissue-selectivity (dermal vs follicular)
Operationally, it works best inside Performance & Recomp memberships that bundle peptides, training guidance, bodycomp scans, and aesthetic services, with automated followups to track waist, strength, energy, and satisfaction, driving both outcomes and recurring revenue